The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer’s Disease: The Role of APP
Open accessAbstract
Overexpression of the amyloid precursor protein (APP) gene on chromosome 21 in Down syndrome (DS) has been linked to increased brain amyloid levels and early-onset Alzheimer’s disease (AD). An elderly man with phenotypic DS and partial trisomy of chromosome 21 (PT21) lacked triplication of APP affording an opportunity to study the role of this gene in the pathogenesis of dementia. Multidisciplinary studies between ages 66–72 years comprised neuropsychological testing, independent neurological exams, amyloid PET imaging with 11 C-Pittsburgh compound-B (PiB), plasma amyloid-β (Aβ) measurements, and a brain autopsy examination. The clinical phenotype was typical for DS and his intellectual disability was mild in severity. His serial neuropsychological test scores showed less than a 3% decline as compared to high functioning individuals with DS who developed dementia wherein the scores declined 17–28% per year. No dementia was detected on neurological examinations. On PiB-PET scans, the patient with PT21 had lower PiB standard uptake values than controls with typical DS or sporadic AD. Plasma Aβ 42 was lower than values for demented or non-demented adults with DS. Neuropathological findings showed only a single neuritic plaque and neurofibrillary degeneration consistent with normal aging but not AD. Taken together the findings in this rare patient with PT21 confirm the obligatory role of APP in the clinical, biochemical, and neuropathological findings of AD in DS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and is in part a result of triplication of the amyloid precursor protein gene (APP) on Hsa21, which results in the increased production of the amyloid-β peptide and other APP gene products [12, 54].”
From Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Down syndrome–Alzheimer’s disease (DSAD) is the most commonly occurring single genetic cause of AD”
From Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly here, we know that raised APP abundance in our DSAD cases is driven by the additional copy of APP on Hsa21, as indicated by both human-genetics studies and preclinical modelling [12, 54, 58].”
From Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a disorder in which an early onset form of AD invariably develops due mainly to a third copy of APP present on trisomic chromosome 21 (Korbel et al., 2009;Doran et al., 2017;Colacurcio et al., 2018).”
From Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99) (2019) · cites this paper as Doran et al., 2017
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This strong gene-dosage effect reinforces the amyloid cascade hypothesis and provides a natural human model of genetically driven amyloidopathy [152, 153].”
From Toward a Unified Framework in Molecular Neurobiology of Alzheimer’s Disease: Revisiting the Pathophysiological Hypotheses (2026) · cites this paper as [152]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Jenkinson, M., Bannister, P., Brady, M., & Smith, S. (2002) · NeuroImage · doi:10.1006/nimg.2002.1132 · Cited by 11,888
Jenkinson, M., Beckmann, C. F., Behrens, T. E. J., Woolrich, M. W., & Smith, S. M. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.09.015 · Cited by 11,314
A global optimisation method for robust affine registration of brain images
Jenkinson, M., & Smith, S. M. (2001) · Medical Image Analysis · doi:10.1016/s1361-8415(01)00036-6 · Cited by 7,018
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894
Primary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467
Rovelet‐Lecrux, A., Hannequin, D., Raux, G., Meur, N. L., Laquerrière, A., Vital, A., Dumanchin‐Njock, C., Feuillette, S., Brice, A., Vercelletto, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1718 · Cited by 1,284
Morris, J. C., Weintraub, S., Chui, H. C., Cummings, J., DeCarli, C., Ferris, S., Foster, N. L., Galasko, D., Graff-Radford, N., Peskind, E. R., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213865.09806.92 · Cited by 950
Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases
Huang, Y., & Mahley, R. W. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.025 · Cited by 829
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
Wiseman, F. K., Al-Janabi, T., Hardy, J., Karmiloff-Smith, A., Nizetic, D., Tybulewicz, V. L. J., Fisher, E. M. C., & Strydom, A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3983 · Cited by 562
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
Jagust, W. J., Bandy, D., Chen, K., Foster, N. L., Landau, S. M., Mathis, C. A., Price, J. C., Reiman, E. M., Skovronsky, D., Koeppe, R. A., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.003 · Cited by 542
Molecular mapping of alzheimer‐type dementia in Down's syndrome
Prasher, V. P., Farrer, M. J., Kessling, A. M., Fisher, E. M. C., West, R. J., Barber, P. C., & Butler, A. C. (1998) · Annals of Neurology · doi:10.1002/ana.410430316 · Cited by 414
Sleegers, K., Brouwers, N., Gijselinck, I., Theuns, J., Goossens, D., Wauters, J., Del‐Favero, J., Cruts, M., van Duijn, C. M., & Broeckhoven, C. V. (2006) · Brain · doi:10.1093/brain/awl203 · Cited by 406
Korbel, J. O., Tirosh-Wagner, T., Urban, A. E., Chen, X.-N., Kasowski, M., Dai, L., Grubert, F., Erdman, C., Gao, M. C., Lange, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813248106 · Cited by 399
Self-citationPhenotype associated with APP duplication in five families
Cabrejo, L., Guyant‐Maréchal, L., Laquerrière, A., Vercelletto, M., Fournière, F. D. L., Thomas-Antérion, C., Verny, C., Letournel, F., Pasquier, F., Vital, A., et al. (2006) · Brain · doi:10.1093/brain/awl237 · Cited by 351
de Jong, H. W. A. M., van Velden, F. H. P., Kloet, R. W., Buijs, F. L., Boellaard, R., & Lammertsma, A. A. (2007) · Physics in Medicine and Biology · doi:10.1088/0031-9155/52/5/019 · Cited by 347
Presence of soluble amyloid β–peptide precedes amyloid plaque formation in Down's syndrome
Teller, J. K., Russo, C., DeBusk, L. M., Angelini, G., Zaccheo, D., Dagna-Bricarelli, F., Scartezzini, P., Bertolini, S., Mann, D. M. A., Tabaton, M., et al. (1996) · Nature Medicine · doi:10.1038/nm0196-93 · Cited by 326
PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., Libri, V., Leppert, D., & Beach, T. G. (2007) · Brain · doi:10.1093/brain/awm191 · Cited by 302
Wang, L. Y., Benzinger, T. L. S., Su, Y., Christensen, J. J., Friedrichsen, K. A., Aldea, P., McConathy, J., Cairns, N. J., Fagan, A. M., Morris, J. C., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2078 · Cited by 301
Alzheimer's disease and Down's syndrome
Mann, D. M. A. (1988) · Histopathology · doi:10.1111/j.1365-2559.1988.tb02018.x · Cited by 246
Korenberg, J. R., Kawashima, H., Pulst, S. M., Ikeuchi, T., Ogasawara, N., Yamamoto, K., Schonberg, S. A., West, R. J., Allen, L., & Magenis, E. (1990) · PubMed · Cited by 242
Psychiatric Disorders in Persons with Down Syndrome
Myers, B. A., & Pueschel, S. M. (1991) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199110000-00004 · Cited by 241
Growth Charts for Children With Down Syndrome in the United States
Zemel, B. S., Pipan, M. E., Stallings, V. A., Hall, W. C., Schadt, K. A., Freedman, D. S., & Thorpe, P. (2015) · PEDIATRICS · doi:10.1542/peds.2015-1652 · Cited by 236
Changes in mortality and causes of death in the Swedish Down syndrome population
Englund, A., Jönsson, B., Zander, C. S., Gustafsson, J., & Annerén, G. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35706 · Cited by 188
Genetic and host factors for dementia in Down's syndrome
Schupf, N. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.405 · Cited by 188
Rosenberg, R. N., Lambracht‐Washington, D., Yu, G., & Xia, W. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0301 · Cited by 149
Crawford, J. R., & Garthwaite, P. H. (2011) · Cortex · doi:10.1016/j.cortex.2011.06.021 · Cited by 147
Protocols to establish genotype-phenotype correlations in Down syndrome.
Epstein, C. J., Korenberg, J. R., Annerén, G., Antonarakis, S. E., Aymé, S., Courchesne, E., Epstein, L. B., Fowler, A. E., Groner, Y., & Huret, J. L. (1991) · PubMed · Cited by 144
Down syndrome and dementia: A randomized, controlled trial of antioxidant supplementation
Lott, I. T., Doran, E., Nguyen, V. Q., Tournay, A., Head, E., & Gillen, D. L. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34114 · Cited by 136
Self-citationImaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B
Handen, B. L., Cohen, A. D., Umapathy, C., Bulova, P. D., Cannon, S. A., Cohen, W. I., Mathis, C. A., Price, J. C., & Klunk, W. E. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.09.229 · Cited by 134
Diagnosing Alzheimer's dementia in Down syndrome: Problems and possible solutions
Mark, R. E. (2009) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2009.01.010 · Cited by 133
On comparing a single case with a control sample: An alternative perspective
Crawford, J. R., Garthwaite, P. H., & Howell, D. C. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.04.011 · Cited by 128
Whither Down syndrome critical regions?
Shapiro, B. L. (1997) · Human Genetics · doi:10.1007/s004390050383 · Cited by 115
Increased plasma amyloid β protein 1–42 levels in Down syndrome
Mehta, P. D., Dalton, A. J., Mehta, S. P., Kim, K. S., Sersen, E. A., & Wisniewski, H. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00966-x · Cited by 108
Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome
Hartley, S. L., Handen, B. L., Devenny, D. A., Hardison, R. M., Mihaila, I., Price, J. C., Cohen, A. D., Klunk, W. E., Seltzer, M. M., Johnson, S. C., et al. (2014) · Brain · doi:10.1093/brain/awu173 · Cited by 100
Accuracy of the clinical diagnosis of Down syndrome.
Devlin, L. K., & Morrison, P. J. (2004) · PubMed · Cited by 99
Kasuga, K., Shimohata, T., Nishimura, A., Shiga, A., Mizuguchi, T., Tokunaga, J., Ohno, T., Miyashita, A., Kuwano, R., Matsumoto, N., et al. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.161703 · Cited by 97
APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage
Rovelet‐Lecrux, A., Frébourg, T., Tuominen, H. J., Majamaa, K., Campion, D., & Remes, A. M. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.113514 · Cited by 95
Plasma Levels of amyloid β proteins Aβ1–40 and Aβ1–42(43) are elevated in Down's syndrome
Tokuda, T., Fukushima, T., Ikeda, S., Sekijima, Y., Shoji, S., Yanagisawa, N., & Tamaoka, A. (1997) · Annals of Neurology · doi:10.1002/ana.410410220 · Cited by 92
Dykens, E. M., Shah, B., Davis, B. A., Baker, C. N., Fife, T., & Fitzpatrick, J. (2015) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-015-9101-1 · Cited by 92
Lao, P. J., Betthauser, T. J., Hillmer, A. T., Price, J. C., Klunk, W. E., Mihaila, I., Higgins, A. T., Bulova, P. D., Hartley, S. L., Hardison, R. M., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.05.013 · Cited by 89
Clinical diagnosis of Down's syndrome
Jackson, J. F., North, E., & Thomas, J. G. (1976) · Clinical Genetics · doi:10.1111/j.1399-0004.1976.tb01601.x · Cited by 87
Weiner, M. W., Veitch, D. P., Hayes, J., Neylan, T. C., Grafman, J. H., Aisen, P. S. S., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.04.005 · Cited by 81
Head, E., Doran, E. W., Nistor, M., HILL, M., Schmitt, F. A., Haier, R. J., & Lott, I. T. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101335 · Cited by 75
Self-citationAge dependence of brain β-amyloid deposition in Down syndrome
Jennings, D. L., Seibyl, J. P., Sabbagh, M. N., Lai, F., Hopkins, W. E., Bullich, S., Gimenez, M., Reininger, C. B., Pütz, B., Stephens, A. W., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001212 · Cited by 74
Positron Emission Tomography of Brain β-Amyloid and Tau Levels in Adults With Down Syndrome
Nelson, L. D., Siddarth, P., Kepe, V., Scheibel, K. E., Huang, S. C., Barrio, J. R., & Small, G. W. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.104 · Cited by 72
Self-citationHaier, R. J., Head, K., Head, E., & Lott, I. T. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.09.064 · Cited by 71
Self-citationZigman, W. B., Schupf, N., Haveman, M. J., & Silverman, W. P. (1997) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1997.tb00679.x · Cited by 71
Strydom, A., & Hassiotis, A. (2003) · Aging & Mental Health · doi:10.1080/13607860310001594682 · Cited by 69
The ECAT HRRT: NEMA NEC evaluation of the HRRT system, the new high-resolution research tomograph
Eriksson, L. I., Wienhard, K., Eriksson, M., Casey, M. E., Knoess, C., Bruckbauer, T., Hamill, J. J., Schmand, M. J., Gremillion, T., Lenox, M., et al. (2002) · IEEE Transactions on Nuclear Science · doi:10.1109/tns.2002.803784 · Cited by 69
Landt, J. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.36 · Cited by 65
Psychiatric Symptoms in Adults With Down Syndrome and Alzheimer's Disease
Urv, T. K., Zigman, W. B., & Silverman, W. P. (2010) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-115.4.265 · Cited by 65
Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome
Wilcock, D. M., Schmitt, F. A., & Head, E. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.007 · Cited by 56
Self-citationSabbagh, M. N. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.535 · Cited by 52
Intracerebral haemorrhage in Down syndrome: protected or predisposed?
Buss, L., Fisher, E., Hardy, J., Nižetić, D., Groet, J., Pulford, L. J., & Strydom, A. (2016) · F1000Research · doi:10.12688/f1000research.7819.1 · Cited by 48
Salivary gland disorders and heredity
Wiedemann, H. ‐. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970120)68:2 · Cited by 45
Mosaicism for Trisomy 21 in a Patient With Young-Onset Dementia
Ringman, J. M., Rao, P. N., Lu, P. H., & Cederbaum, S. D. (2008) · Archives of Neurology · doi:10.1001/archneur.65.3.412 · Cited by 43
Does Down's syndrome support the homocysteine theory of atherogenesis?
Licastro, F., Marocchi, A., Penco, S., Porcellini, E., Lio, D., Dogliotti, G., & Romanelli, M. M. C. (2006) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2006.01.003 · Cited by 39
Walsh, D. M. A., Doran, E. W., Silverman, W. P., Tournay, A. E., Movsesyan, N., & Lott, I. T. (2015) · Journal of Intellectual Disability Research · doi:10.1111/jir.12200 · Cited by 32
Self-citationIs Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?
Rohn, T. T., McCarty, K. L., Love, J. E., & Head, E. (2014) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000004 · Cited by 22
Self-citationA patient with partial trisomy 21 and 7q deletion expresses mild Down syndrome phenotype
Papoulidis, I., Papageorgiou, E., Siomou, E., Oikonomidou, E., Thomaidis, L., Vetro, A., Zuffardi, O., Liehr, T., Manolakos, E., & Vassilis, P. (2013) · Gene · doi:10.1016/j.gene.2013.11.078 · Cited by 22
Diagnosis of Down's Syndrome: Clinical vs. Laboratory
Lee, L. G., & Jackson, J. F. (1972) · Clinical Pediatrics · doi:10.1177/000992287201100610 · Cited by 20
The ECAT HRRT: NEMA NEC evaluation of the HRRT system, the new High Resolution Research Tomograph
Wienhard, K., Eriksson, L., Eriksson, M., Casey, M. E., Knoess, C., Bruckbauer, T., Hamill, J., Schmand, M., Gremillion, T., Lenox, M., et al. (2005) · IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) · doi:10.1109/nssmic.2001.1008557 · Cited by 6
Flagged first, then by citations
Research works printed but not linked: 10
- Korenberg JR, 1990, Am J Hum Genet, 47, 236
- Devlin L, 2004, Ulster Med J, 73, 4
- Ossendorf M, 2000, Qiagen News, 1, 11
- Wechsler D, 1997, WAIS-III administration and scoring manual
- Sparrow S, 2005, Vineland adaptive behavior scales: (Vineland II), survey interview form/caregiver rating form
- Weiner MW, 2014, Alzheimers Dement, 1, S226
- Holm S, 1979, Scand J Stat, 6, 65
- R Core Team, 2014, A Language and Environment for Statistical Computing
- Rohn TT, 2014, J Parkinsons Dis Alzheimers Dis, 1, 7
- Epstein CJ, 1991, Am J Hum Genet, 49, 207
Cited by
Sorted by citations
Antonarakis, S. E., Skotko, B. G., Rafii, M. S., Strydom, A., Pape, S. E., Bianchi, D. W., Sherman, S. L., & Reeves, R. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0143-7 · Cited by 964
Alzheimer’s disease: risk factors and potentially protective measures
Silva, M. V. F., Loures, C. D. M. G., Alves, L. C. V., de Souza, L. C., Borges, K. B. G., & Ferriani, M. D. G. C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0524-y · Cited by 1,031
Dementia in Down syndrome: unique insights for Alzheimer disease research
Lott, I. T., & Head, E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0132-6 · Cited by 383
Self-citationAlzheimer's disease associated with Down syndrome: a genetic form of dementia
Fortea, J., Zaman, S. H., Hartley, S., Rafii, M. S., Head, E., & Carmona-Iragui, M. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00245-3 · Cited by 357
Self-citationAlzheimer’s Disease: An Updated Overview of Its Genetics
Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodríguez, I., Cadena-Suárez, A. R., Sánchez-Garibay, C., Pozo-Molina, G., Méndez-Catalá, C. F., Cardenas-Aguayo, M.-D.-C., Diaz-Cintra, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043754 · Cited by 336
Metadata
- Authors
- Doran, E., Keator, D., Head, E., Phelan, M. J., Kim, R., Totoiu, M., Barrio, J. R., Small, G. W., Potkin, S. G., & Lott, I. T.
- Affiliations
- University of California, Irvine Medical Center (US)
- University of California, Irvine (US)
- University of Kentucky (US)
- University of California, Los Angeles (US)
- Corresponding author
- Lott, Ira T.
- ORCID
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2016-12-09
- Volume
- 56
- Issue
- 2
- Pages
- 459-470
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC5662115
- OpenAlex
- W2567009735
- Cited by
- 244
- References
- 68
- Citations by year
- 2026: 16 · 2025: 45 · 2024: 35 · 2023: 25 · 2022: 31 · 2021: 28 · 2020: 21 · 2019: 27 · 2018: 11 · 2017: 5
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (UL1TR000153)
- National Institute on Aging (P50AG016573, R01AG021912, U01AG051412, R01AG033015, U19AG068054, U24AG021886)
- National Institute of Mental Health (U01MH097435)
- National Center for Research Resources (U24RR021992, P20RR020837)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD065160, R01HD064993)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Down syndrome, partial trisomy 21
- MeSH terms
- Aged, Alzheimer Disease, Brain, Down Syndrome, Humans, Male, Phenotype, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
